Could your own stem cells ease pancreatitis pain?

NCT ID NCT05925036

Recruiting now Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests whether stem cells taken from a patient's own bone marrow can reduce pain caused by chronic pancreatitis and possibly improve pancreas function. Forty adults with long-term painful pancreatitis will receive either the stem cells or a placebo. The study focuses on safety and pain changes over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mesenchymal stem cells (MSCs) from the patient's own bone marrow
What this could lead to: If it works, this could point toward a new way to manage chronic pain and improve quality of life for people with chronic pancreatitis.
What could go wrong: This is an early Phase 1 trial with only 40 participants, so it is too soon to know if it works. The main goal is safety, and pain relief may not be achieved.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome chronic pancreatitis Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN CHRONIC PANCREATITIS

Contacts and locations

Locations

Ralph H. Johnson VA Medical Center, Charleston, SC
RECRUITING

Charleston, South Carolina, 29401-5703, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.